Edison Investment Research - Finsbury Growth Income Trust PLC (FGT) Finsbury Growth Income Trust - Another new addition to the fund â€“ Fever-Tree

Report

Edison Investment Research

Pedro Fonseca

Finsbury Growth & Income Trust - Another new addition to the fund â€“ Fever-Tree

Finsbury Growth & Income Trust (FGT) has been managed by Nick Train since January 2001. Given the economic uncertainty due to the global COVID-19 pandemic, he stresses the importance of determining which companies will survive and thrive, and which could ultimately fail. The manager also seeks to invest in firms that can take advantage of the upsurge in digital and software services, as technology is advancing at an accelerating pace. While Train rarely initiates new holdings in the fund, in recent months he has added a position in premium mixer producer Fever-Tree, taking advantage of a significant pullback in its share price. FGT has a very strong performance record and has outpaced the broad UK market over the last one, three, five and 10 years.

09/06/2020 10 EN

Underlying

Finsbury Growth & Income Trust PLC

Finsbury Growth & Income Trust is an investment trust company. Co.'s investment policy is to invest principally in the securities of U.K. listed companies, whilst up to a maximum of 20.0% of its portfolio, at the time of acquisition, can be invested in quoted companies worldwide. The portfolio will normally comprise up to 30 investments. Co. has appointed Frostrow Capital LLP (Frostrow) as alternative investment fund manager to provide company management, company secretarial, administrative and marketing services. Co. and Frostrow have jointly appointed Lindsell Train Limited as portfolio manager.

See profile

GB0007816068 London Stock Exchange United Kingdom

Provider

Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

See profile

Analysts

Pedro Fonseca

Other Reports on these Companies

EQS Group AG

Edison issues update on Finsbury Growth & Income Trust (FGT): Train puts his money where his mouth is

Edison Investment Research Limited Edison issues update on Finsbury Growth & Income Trust (FGT): Train puts his money where his mouth is 14-May-2024 / 13:47 GMT/BST The issuer is solely responsible for the content of this announcement. London, UK, 14 Mai 2024 Edison issues update on Finsbury Growth & Income Trust (FGT): Train puts his money where his mouth is Finsbury Growth & Income Trust (FGT) has been managed by Lindsell Train since the beginning of 2001. During his long tenure, approaching a quarter of a century, lead manager Nick Train has steadily acquired a signifi...

May 14, 2024 May 14, 2024 1 EN

Edison Investment Research

Finsbury Growth & Income Trust - Train puts his money where his mouth is

Finsbury Growth & Income Trust (FGT) has been managed by Lindsell Train since the beginning of 2001. During his long tenure, approaching a quarter of a century, lead manager Nick Train has steadily acquired a significant 2.9% personal holding in the trust, which is a considerable amount of ‘skin in the game’. From the beginning of 2001 until the end of 2023, FGT’s 9.0% annual NAV total return was comfortably ahead of the UK market’s 5.1% annual total return. However, Train and deputy manager Madeline Wright, who was appointed in 2019, have underperformed for the last three years. The managers ...

May 14, 2024 May 14, 2024 1 EN

SmartInsider

Finsbury Growth & Income Trust: 1 director

A director at Finsbury Growth & Income Trust bought 25,000 shares at 862p and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The n...

Free Trial

March 7, 2024 March 7, 2024 1 EN

Basilea Pharmaceutica - Cresemba milestone payments continue to roll in

Basilea Pharmaceutica has announced the triggering of a US$1.25m milestone payment from Pfizer, triggered by sustained strong sales of Cresemba in the Asia-Pacific region and China. This is the second FY24 milestone payment for the region and is incremental to the payment received in March. We note that, according to the latest available data, total in-market sales of Cresemba amounted to US$473m in the 12 months ending December 2023, representing a +26% year-on-year increase. Basilea is preparing to launch its Phase III programme for fosmanogepix, a broad-spectrum antifungal therapy, with the...

20h / 36m 20h / 36m 1 EN

Toby Thorrington

Toby Thorrington

AAC Clyde Space - Solid start to the year with further order growth

AAC Clyde Space offers exposure to the fast-growing low Earth orbit space market. A solid start to the year and continued order momentum are encouraging. We also note the internal restructuring to promote delivery of the group’s products and services. We expect this combination to drive an improving performance, albeit within the lumpy nature of the business, in turn improving investor confidence and the stock’s valuation.

22h / 30m 22h / 30m 1 EN

Richard Williamson

Richard Williamson

Tinexta - Typical seasonality in Q124

Tinexta’s Q124 results showed good progress in the two divisions that typically demonstrate more consistent (through the year) growth, Cyber Security and Digital Trust, which management expects to deliver higher growth over the next few years. Business Innovation demonstrated its typical seasonality and management therefore remains confident about the outlook for the year.

23h / 57m 23h / 57m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Finsbury Growth & Income Trust - Another new addition to the fund â€“ Fever-Tree

Edison issues update on Finsbury Growth & Income Trust (FGT): Train puts his money where his mouth is

Finsbury Growth & Income Trust - Train puts his money where his mouth is

Finsbury Growth & Income Trust: 1 director

Basilea Pharmaceutica - Cresemba milestone payments continue to roll in

AAC Clyde Space - Solid start to the year with further order growth

Tinexta - Typical seasonality in Q124

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe